
MAPK
MAPKs are a family of protein kinases involved in a variety of cellular processes, including growth, proliferation, differentiation, and stress responses. The MAPK signaling pathway consists of several tiers, including ERK, JNK, and p38 MAPKs, each playing distinct roles in cellular function. Dysregulation of MAPK signaling is linked to cancer, inflammatory diseases, and metabolic disorders. At CymitQuimica, we offer a wide array of MAPK inhibitors and activators to support your research in cell biology, signal transduction, and disease mechanisms.
Found 885 products of "MAPK"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
ERK1/2 inhibitor 1
CAS:<p>ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1/2 inhibitor, showing 60% inhibition at 1 nM and an IC50 of 3.0 nM against ERK1 and ERK2, respectively.</p>Formula:C29H32ClN5O4Purity:98.81%Color and Shape:SolidMolecular weight:550.05PF-05381941
CAS:<p>PF-05381941 is a selective and potent dual inhibitor of TAK1 and p38α that inhibits the kinase activity of TAK1 by binding to its active site.</p>Formula:C27H26N6O2Purity:98.04%Color and Shape:SolidMolecular weight:466.53MEK-IN-1
CAS:<p>MEK-IN-1 is a MEK inhibitor.</p>Formula:C24H20N4O4Purity:98%Color and Shape:SolidMolecular weight:428.44PAF (C16)
CAS:<p>PAF (C16) is a potent MAPK and MEK/ERK activator that induces increased vascular permeability.</p>Formula:C26H54NO7PPurity:98%Color and Shape:SolidMolecular weight:523.68B-Raf IN 13
CAS:<p>B-Raf IN 13 is a potent B-Raf inhibitor with anticancer activity.B-Raf IN 13 has an IC50 of 3.55 nM in the BRAF V600E enzyme assay.</p>Formula:C19H19ClFN3O4SPurity:99.41% - >99.99%Color and Shape:SoildMolecular weight:439.89KRAS G12D inhibitor 10
CAS:<p>KRAS G12D inhibitor 10 targets KRAS G12D in cancer research (WO2021108683A1, compound 34).</p>Formula:C33H41ClN8O2Color and Shape:SolidMolecular weight:617.18GGTI-286
CAS:<p>GGTI-286: GGTase I inhibitor, cell-permeable, IC50=2μM. Strongly blocks Rap1A geranylation; less effective on H-Ras, Ras4B IC50=1μM.</p>Formula:C23H31N3O3SColor and Shape:SolidMolecular weight:429.58MCP110
CAS:<p>MCP110 is an inhibitor of the interaction of Ras with Raf-1 and can be used in studies about the treatment of human tumors.</p>Formula:C33H36N2O3Purity:97.23%Color and Shape:OilMolecular weight:508.65KYA1797
CAS:<p>KYA1797 inhibits Wnt/ß-catenin, targeting axin, and promotes ß-catenin/Ras decay, halting APC/KRAS mutant CRC growth.</p>Formula:C17H12N2O6S2Purity:98%Color and Shape:SolidMolecular weight:404.42RSK2-IN-2
CAS:<p>RSK2-IN-2 (Compound 25) is a reversible covalent inhibitor of the RPS6KA3 ( RSK2 ) kinase which also inhibits MSK1, MSK2, and RSK3 [1].</p>Formula:C16H11N5OColor and Shape:SolidMolecular weight:289.29GABAB receptor antagonist 1
CAS:<p>(E)-GABAB receptor antagonist 1 decreases GABA-induced IP3 (inositol trisphosphate) production with IC50 of 37.9 μM.GABAB receptor antagonist 1 is a selective</p>Formula:C18H24O4Purity:98%Color and Shape:SolidMolecular weight:304.38B-Raf IN 8
CAS:<p>B-Raf IN 8: strong B-Raf inhibitor (70.65 nM IC50); combats liver, colon, breast & prostate cancer with IC50s from 9.78 to 29.85 μM.</p>Formula:C18H17N3O2Color and Shape:SolidMolecular weight:307.35HPK1-IN-24
CAS:<p>HPK1-IN-24 (example 51) has potential to be used in the cancer research which is an inhibitor of hematopoietic progenitor kinase 1 (HPK1) (Ki = 100 nM) [1].</p>Formula:C19H14FN5Color and Shape:SolidMolecular weight:331.35UC-857993
CAS:<p>UC-857993 is a selective SOS1-Ras inhibitor with a Kd of 14.7 μM that inhibits ERK, Ras, and reduces MEF growth.</p>Formula:C25H22ClNO2Color and Shape:SolidMolecular weight:403.9JNK3 inhibitor-2
CAS:<p>JNK3 inhibitor-2: selectively inhibits JNK3 (IC50 = 0.25 μM); less effective on JNK1/JNK2 (>100 μM); targets DDR1 and EGFR mutations.</p>Formula:C20H14N2O2Color and Shape:SolidMolecular weight:314.34Tpl2 Kinase Inhibitor 1
CAS:<p>Tpl2 Kinase Inhibitor 1 is an effective and selective Tpl2 inhibitor.</p>Formula:C21H14ClFN6Purity:98%Color and Shape:SolidMolecular weight:404.83SX 011
CAS:<p>SX 011 is a p38α inhibitor.</p>Formula:C26H27ClFN3O3Purity:98%Color and Shape:SolidMolecular weight:483.96KRAS inhibitor-7
CAS:<p>KRAS inhibitor-7 is a potent KRAS G12C inhibitor.</p>Formula:C26H27ClF2N6O2Purity:98%Color and Shape:SolidMolecular weight:528.98HPK1-IN-25
CAS:<p>HPK1-IN-25, an HPK1 inhibitor, IC50 129 nM, may aid cancer research.</p>Formula:C23H25N5OColor and Shape:SolidMolecular weight:387.48KRAS G12C inhibitor 43
CAS:<p>KRAS G12C inhibitor 43 strongly blocks KRAS G12C, H358 cell growth (IC50: 0.001-1μM), less effective on A549, HCC cells (IC50>1μM).</p>Formula:C33H35N7O3Color and Shape:SolidMolecular weight:577.68GGTI-286 hydrochloride
CAS:<p>GGTI-286 HCl strongly inhibits GGTase I (IC50: 2 μM) and K-Ras4B farnesylation (IC50: 1 μM).</p>Formula:C23H32ClN3O3SColor and Shape:SolidMolecular weight:466.04SMAP-2
CAS:<p>SMAP-2: oral PP2A activator, targets Aα subunit, halts KRAS-mutant lung cancer growth.</p>Formula:C27H27F3N2O4SPurity:98%Color and Shape:SolidMolecular weight:532.57HPK1-IN-26
CAS:<p>HPK1-IN-26, from WO2021254118A1, is a potent dual HPK1/GLK inhibitor for studying animal infections.</p>Formula:C19H21N5OSColor and Shape:SolidMolecular weight:367.47ZINC09659342
CAS:<p>ZINC09659342 (compound 13) is an inhibitor of Lbc-RhoA interaction (IC50: 3.6 μM).</p>Formula:C23H15F3N2O4Color and Shape:SolidMolecular weight:440.37NSC-658497
CAS:<p>NSC-658497 is a SOS1-Ras interaction inhibitor that acts by dose-dependently inhibiting SOS1 GEF activity.</p>Formula:C20H10N2O6S2Purity:98%Color and Shape:SolidMolecular weight:438.43SR 3576
CAS:<p>JNK3 inhibitor, potent and selective</p>Formula:C27H27N5O5Purity:98%Color and Shape:SolidMolecular weight:501.53CAY10561
CAS:<p>CAY10561: potent, selective ERK2 inhibitor (Ki=2nM); blocks cell proliferation; IC50 in COLO 205 cells: 0.54μM.</p>Formula:C22H17Cl2FN4O2Color and Shape:SolidMolecular weight:459.3KRAS G12C inhibitor 22
CAS:<p>KRAS G12C inhibitor 22 is a KRAS G12C inhibitor.</p>Formula:C32H41N7O2Color and Shape:SolidMolecular weight:555.71Quazinone
CAS:<p>Quazinone: PDE3 inhibitor, enhances heart muscle contractility, lowers blood pressure, and inhibits DNA synthesis in muscle cells. IC50 = 4.2 μM.</p>Formula:C11H10ClN3OColor and Shape:SolidMolecular weight:235.67SB-747651A
CAS:<p>SB-747651A: ATP-competitive MSK1 inhibitor (IC50=11nM), affects N-terminal domain, also hinders MSK2, PKA, PKB, RSK, p70S6K.</p>Formula:C16H22N8OPurity:98%Color and Shape:SolidMolecular weight:342.4EO 1428
CAS:<p>p38α and p38β2 inhibitor</p>Formula:C20H16BrClN2OPurity:98%Color and Shape:SolidMolecular weight:415.71PD 334581
CAS:<p>MEK1 inhibitor</p>Formula:C20H19F3IN5O2Purity:98%Color and Shape:SolidMolecular weight:545.3p38α inhibitor 2
CAS:<p>P38α Inhibitor 2, a potent and selective inhibitor of p38α MAPK, exhibits a pIC50 value of 9.6.</p>Formula:C27H33N5O3Color and Shape:SolidMolecular weight:475.58pan-KRAS-IN-16
CAS:<p>3344 is an inhibitor of KRAS-effector interactions,with an affnity of 126nm.</p>Formula:C24H26N2O3Purity:98%Color and Shape:SolidMolecular weight:390.47B-Raf IN 6
CAS:<p>B-Raf IN 6: potent B-Raf kinase inhibitor, IC50 of 1.7 nM, doesn't target PXR, metabolically stable, potential in cancer research.</p>Formula:C24H21F3N6O2S2Color and Shape:SolidMolecular weight:546.59(R)-CE3F4
CAS:<p>(R)-CE3F4 is a selective inhibitor of exchange protein directly activated by cAMP isoform 1 (Epac1)(IC50 of 4.2 μM),</p>Formula:C11H10Br2FNOColor and Shape:SolidMolecular weight:351.01SR-3737
CAS:<p>SR-3737 is potent both JNK3 and p38 inhibitor.</p>Formula:C29H25FN4O4Purity:98%Color and Shape:SolidMolecular weight:512.53TOPK-p38/JNK-IN-1
CAS:<p>TOPK-p38/JNK-IN-1 (Compound B12) is an orally active inhibitor of the TOPK-p38/JNK signaling pathway, with an IC50 value of 2.14 μM for the inhibition of NO</p>Formula:C17H15F3N2O4Color and Shape:SolidMolecular weight:368.31B-Raf IN 7
CAS:<p>"B-Raf IN 7 inhibits B-Raf (IC50: 110.23 nM); fights colon, breast, liver, cervical, prostate cancers (IC50: 7.50-12.83 μM)."</p>Formula:C15H16N6O3Color and Shape:SolidMolecular weight:328.33KB-5246
CAS:<p>KB-5246, displays antibacterial activities.is a tetracyclic quinolone.</p>Formula:C18H17ClFN3O4SPurity:98%Color and Shape:SolidMolecular weight:425.86KRas G12C inhibitor 4
CAS:<p>KRas G12C inhibitor 4 is a compound that inhibits KRas G12C.</p>Formula:C33H38ClN7O2Purity:98%Color and Shape:SolidMolecular weight:600.15Avutometinib potassium
CAS:<p>Avutometinib potassium, a MEKi, blocks Delta and Omicron infection in airway cells, potentially lessening disease severity.</p>Formula:C21H17FKN5O5SColor and Shape:SolidMolecular weight:509.553,4-Dephostatin
CAS:<p>3,4-Dephostatin is an inhibitor of the interactions of CFTR-associated ligand (CAL) and PSD-95/Dlg1/ZO-1 (PDZ) domain.</p>Formula:C7H8N2O3Color and Shape:SolidMolecular weight:168.15ERK5-IN-3
CAS:<p>ERK5-IN-3 inhibits ERK5 strongly (IC50: 6 nM) and hampers Hela cell growth (IC50: 31 nM).</p>Formula:C24H23Cl2FN4O2Color and Shape:SolidMolecular weight:489.37Ras modulator-1
CAS:<p>Ras modulator-1 is a modulator of Ras.</p>Formula:C29H21N5O4SColor and Shape:SolidMolecular weight:535.57KRas G12C inhibitor 3
CAS:<p>KRas G12C inhibitor 3 is a compound that inhibits KRas G12C.</p>Formula:C32H36ClN7O2Purity:98%Color and Shape:SolidMolecular weight:586.13MW108
CAS:<p>MW108 is an active site targeted, CNS-active, p38αMAPK inhibitor.</p>Formula:C21H19ClN4Color and Shape:SolidMolecular weight:362.86(S)-CCG-1423
<p>(S)-CCG-1423, a stereoisomer, inhibits Rho to block myocardin-related transcription factor A & serum response signaling.</p>Formula:C18H13ClF6N2O3Purity:98%Color and Shape:SolidMolecular weight:454.8K-Ras G12C-IN-3
CAS:<p>K-Ras G12C-IN-3: novel, irreversible inhibitor of K-Ras G12C mutant protein for cancer treatment.</p>Formula:C21H19Cl3N2O3Color and Shape:SolidMolecular weight:453.75ML 3403
CAS:<p>p38 MAPK inhibitor; IC50: 0.38μM. Reduces IL-1β & TNF-α release in PBMC assay; IC50: 0.039μM & 0.16μM.</p>Formula:C23H21FN4SColor and Shape:SolidMolecular weight:404.5
